glp-1 meaning Agonists - What is it? The GLP-1 Agonists and Obesity:
Description
Meanwhile, orforglipron demonstrated significant weight loss efficacy [8] consistent with injectable GLP-1 medicines

Indias pharma industry is strong

CMC Weight Loss is helping patients with GLP-1 options utilizing Medicare initiatives that make life-changing medications more affordable.
Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain

The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.
But for complex drugs like this, quality control is still improving